Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-09-069045
Filing Date
2009-03-31
Accepted
2009-03-31 13:55:08
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 195571
2 EMPLOYMENT AGREEMENT - THOMAS SILBERG dex1026.htm EX-10.26 56220
3 EMPLOYMENT AGREEMENT - RICHARD TAJAK dex1027.htm EX-10.27 52102
4 EMPLOYMENT AGREEMENT - FRANK HARMON dex1028.htm EX-10.28 51891
5 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 3125
6 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 7686
7 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 7670
8 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 4326
9 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 4067
  Complete submission text file 0001193125-09-069045.txt   384214
Mailing Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808
Business Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 49 6172 608 2327
Fresenius Kabi Pharmaceuticals Holding, Inc. (Filer) CIK: 0001439449 (see all company filings)

EIN.: 980589183 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34172 | Film No.: 09717664
SIC: 2834 Pharmaceutical Preparations